MedTrace Logo

Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer

NCT06492785 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 858

Last updated 2025-12-05

No results posted yet for this study

Summary

The purpose of this study is to compare the live birth rates of high concentration of Hyaluronic Acid (0.5 mg/ml) transfer medium (EmbryoGlue®) to those containing low Hyaluronic Acid concentrations (0.125 mg/ml) (G2 medium) in women undergoing single fresh and frozen blastocyst transfer.

Conditions

Interventions

BIOLOGICAL

High Hyaluronic Acid concentrations (0.5 mg/ml)

Hyaluronic Acid(EmbryoGlue®)

BIOLOGICAL

Low Hyaluronic Acid concentrations (0.125 mg/ml)

Hyaluronic Acid (G2 medium)

Sponsors & Collaborators

  • Jiangxi Maternal and Child Health Hospital

    collaborator OTHER

  • Gansu Provincial Maternal and Child Health Care Hospital

    collaborator OTHER

  • Huazhong University of Science and Technology

    collaborator OTHER

  • Northwest Women's and Children's Hospital, Xi'an, Shaanxi

    lead OTHER

Principal Investigators

  • Juanzi Shi, Doctor · Center for Reproductive Medicine, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-13
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06492785 on ClinicalTrials.gov